Diplomat to fill Xermelo prescriptions for patients with carcinoid syndrome diarrhea

Lexicon Pharmaceuticals’ Xermelo was recently approved with orphan status by the Food and Drug Administration (FDA) and Diplomat, the USA largest independent specialty pharmacy, will fill prescriptions for it, as it has been selected to the limited-distribution panel of the drug.

Read more

Penn Researchers, Diplomat study shows: Nearly 50% Medicaid hepatitis C patients denied therapies as not considered “a medical necessity”

Nearly 50 percent of Medicaid patients infected with chronic hepatitis C virus (HCV) whose doctors had prescribed newer, life-saving antiviral drugs were denied coverage to the therapies because they were not considered “a medical necessity.”

Read more